Stock Detail
$LLY
Healthcare · 22 tracked mentions in the last 90 days across 13 creators.
Valuation and creator stance reflect the last 90 days. The mention feed below shows the latest tracked mentions across all history.
4 creators lean undervalued while 2 lean overvalued, so the live read stays mixed instead of forcing a one-sided call on LLY.
Creator Evidence
Why creators say this
Explicit claim • strong conviction • basis: multiple relative
And so, Eli Lilly's valuation is not overvalued. In fact, I feel like the stock is undervalued at a forward P/E of 24. It's still near the low end of what the stock has traded at based on that metric going back 3 years.
Implied claim • moderate conviction • basis: priced for perfection
too late
Implied claim • strong conviction • basis: growth vs multiple
Can you imagine owning Eli Lilly stock today? It's one of the biggest growth monsters in the pharma sector, isn't it? Every pharma investor wants to own Lilly stock because of the massive growth that it's achieved. Can you imagine it also paying out over a 10% dividend yield?
Implied claim • weak conviction • basis: growth vs multiple
their P/E ratio is a 38. You might dismiss them. Oh, too expensive, overpriced, trading for a fat premium that doesn't justify.
Mention History
Latest mentions across all history
Feed